These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19085770)

  • 1. [Erythropoietin - state of science].
    Schöffel N; Börger JA; Quarcoo D; Scutaru C; Groneberg DA
    Sportverletz Sportschaden; 2008 Dec; 22(4):201-6. PubMed ID: 19085770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F; Lee A
    Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and analogs.
    Reichel C; Gmeiner G
    Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and the heart: facts and perspectives.
    Mastromarino V; Volpe M; Musumeci MB; Autore C; Conti E
    Clin Sci (Lond); 2011 Jan; 120(2):51-63. PubMed ID: 20929439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model.
    Kitamura H; Isaka Y; Takabatake Y; Imamura R; Suzuki C; Takahara S; Imai E
    Nephrol Dial Transplant; 2008 May; 23(5):1521-8. PubMed ID: 18194980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The erythropoietin receptor in normal and cancer tissues.
    Jelkmann W; Bohlius J; Hallek M; Sytkowski AJ
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):39-61. PubMed ID: 18434185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overview of erythropoietin].
    Lacombe C; Mayeux P; Casadevall N
    Nephrologie; 1991; 12(5):221-6. PubMed ID: 1662784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
    Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH
    J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis.
    Adamson JW
    Soc Gen Physiol Ser; 1988; 43():57-65. PubMed ID: 2855867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
    Smith K; Semple D; Bhandari S; Seymour AM
    Eur J Heart Fail; 2009 Aug; 11(8):732-8. PubMed ID: 19633100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel renoprotective actions of erythropoietin: new uses for an old hormone.
    Johnson DW; Forman C; Vesey DA
    Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin: a new tool for muscle disorders?
    Scoppetta C; Grassi F
    Med Hypotheses; 2004; 63(1):73-5. PubMed ID: 15193351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin: indications and measurement].
    Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
    Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
    Fliser D; Haller H
    Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analytical approach for detection of carbamylated erythropoietin for doping control purposes.
    Kaliszewski P; Siek P; Zalewska Z; Michalak D; Kwiatkowska D
    Drug Test Anal; 2020 Nov; 12(11-12):1599-1604. PubMed ID: 33119952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin after a century of research: younger than ever.
    Jelkmann W
    Eur J Haematol; 2007 Mar; 78(3):183-205. PubMed ID: 17253966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin (Epo) receptor and Epo mimetics.
    Lacombe C; Mayeux P
    Adv Nephrol Necker Hosp; 1999; 29():177-89. PubMed ID: 10561744
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span.
    Sanchez PE; Navarro FP; Fares RP; Nadam J; Georges B; Moulin C; Le Cavorsin M; Bonnet C; Ryvlin P; Belmeguenai A; Bodennec J; Morales A; Bezin L
    J Comp Neurol; 2009 Jun; 514(4):403-14. PubMed ID: 19330822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.